[ET Net News Agency, 10 August 2026] HANSOH PHARMA (03692) rose 3.8% to HK$34.16.
It hits an intra-day high of HK$34.16, breaking above the 100-D SMA of HK$33.397, and an intra-day low of HK$33.24. The total shares traded was 8.7 million, with a value of HK$292.14m. The active buy/sell ratio is 55:45, with net buying turnover of HK$26.34m. MORGAN STANLEY HK SEC accounts for greatest net responsive buying turnover of HK$11.51m, with volume weighted average price of HK$33.534. CLSA LTD accounts for greatest net responsive selling turnover of HK$24.38m, with volume weighted average price of HK$33.56. The stock has risen a combined 8.8% over the past 4 consecutive trading days.
The Hang Seng Index now rose 150 points, or 0.6% to 25,818; the Hang Seng China Enterprises Index now rose 45 points, or 0.5% to 8,577.
Basic Information| Nominal | 34.160 | % Chg | +3.77% |
| High | 34.160 | Low | 33.240 |
| Shares Tr | 8.7m | Turnover | 292.14m |
| 10-D SMA | 32.344 | %H.V | 33.951 |
| 20-D SMA | 32.468 | VWAP | 33.570 |
| 50-D SMA | 31.160 | RSI14 | 62.375 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 55:45, with net buying turnover of HK$26.34m, rising a combined 8.8% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 34.160 | +3.77 |
| SIHUAN PHARM (00460) | 0.900 | -0.55 |
| GRAND PHARMA (00512) | 5.450 | +4.11 |
| SBP GROUP (01177) | 5.030 | -1.28 |
| HENGRUI PHARMA (01276) | 57.500 | -1.71 |
| LIVZON PHARMA (01513) | 26.680 | +0.76 |
| LUYE PHARMA (02186) | 2.120 | -0.47 |
| FOSUN PHARMA (02196) | 17.080 | +0.23 |
| SH PHARMA (02607) | 11.840 | -0.25 |
| CHINARES PHARMA (03320) | 4.845 | +0.10 |
(ed)
